EE153 Cost-Minimization of Oral Valganciclovir Vs Intravenous Ganciclovir for Cytomegalovirus Prophylaxis in Renal Transplant Recipients
Abstract
Authors
Junior JM Alves FE Prota JCB Martinelli A Chrispim FF Christoforo M Serpeloni I Barreto